Copyright
©The Author(s) 2022.
World J Crit Care Med. Mar 9, 2022; 11(2): 85-91
Published online Mar 9, 2022. doi: 10.5492/wjccm.v11.i2.85
Published online Mar 9, 2022. doi: 10.5492/wjccm.v11.i2.85
Variable | NEUi non-users, n = 30 | NEUi users, n = 27 | P |
Age in yr | 60.1 ± 14.5 | 67.6 ± 11.9 | 0.039 |
Men/Women, n (%) | 11 (36.7)/19 (63.3) | 9 (33.3)/18 (66.7) | 0.988 |
Follow-up in yr | 4.0 ± 2.7 | 4.5 ± 3.3 | 0.504 |
Dead at follow-up, n (%) | 17 (56.7) | 7 (25.9) | 0.038 |
BMI in kg/m2 | 23.5 ± 3.5 | 25.9 ± 4.4 | 0.025 |
Arterial hypertension, n (%) | 12 (40.0) | 20 (74.1) | 0.020 |
Smoking habits, n (%) | 6 (20.0) | 14 (51.9) | 0.025 |
Dyslipidemia, n (%) | 7 (23.3) | 12 (44.4) | 0.160 |
Diabetes mellitus, n (%) | 2 (6.7) | 5 (18.5) | 0.339 |
Supraventricular arrhythmias, n (%) | 4 (13.3) | 7 (25.9) | 0.386 |
Coronary artery disease, n (%) | 0 (0) | 5 (18.5) | 0.046 |
eGFR in mL/min/1.73 m2 [CKD-EPI] | 73.7 ± 24.7 | 58.7 ± 22.7 | 0.022 |
WHO-FC | 2.2 ± 0.76 | 2.3 ± 0.47 | 0.572 |
6MWD in m | 383.9 ± 129.7 | 374.3 ± 145.1 | 0.845 |
NT-proBNP in ng/mL | 714.9 ± 692.4 | 808.7 ± 617.9 | 0.593 |
Systolic PAP in mmHg | 74.7 ± 26.3 | 71.0 ± 21.3 | 0.569 |
Diastolic PAP in mmHg | 27.5 ± 11.6 | 26.3 ± 9.6 | 0.681 |
Mean PAP in mmHg | 46.2 ± 16.1 | 43.6 ± 13.6 | 0.509 |
Right atrial pressure in mmHg | 8.3 ± 3.9 | 10.5 ± 5.0 | 0.063 |
PAWP in mmHg | 10.5 ± 2.9 | 11.7 ± 2.5 | 0.105 |
PVR in Wood unit | 9.0 ± 5.4 | 8.6 ± 4.6 | 0.789 |
Cardiac index in L/min/m2 | 2.6 ± 0.9 | 2.4 ± 0.6 | 0.258 |
- Citation: Scagliola R, Brunelli C, Balbi M. Treatment with neurohormonal inhibitors and prognostic outcome in pulmonary arterial hypertension with risk factors for left heart disease. World J Crit Care Med 2022; 11(2): 85-91
- URL: https://www.wjgnet.com/2220-3141/full/v11/i2/85.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v11.i2.85